Hoy show full stories X To see all the stories in an enlarged form, please register. Get a free trial Send information | ||||
recommendations | Son's price target lowered to CHF 253 from CHF 260 at Deutsche Bank» 15:06 sati 22/05/23 15:06 sati 15:06 sati Sinc Sonova +1,5(+2,70%) Analista de Deutsche Bank... The story is temporarily locked. Get a free trial projectionTo hideRelated things>><<
|
Wednesday | ||||
recommendations | Son's price target lowered to CHF 300 from CHF 315 at Barclays» 15:04 sati 17/05/23 15:04 sati 15:04 sati Sinc Sonova -6,6616(-10,72%) Hassan, an analyst at Barclays... Barclays analyst Hassan Al-Wakeel cut the company's price target for Sonova to CHF 300 from CHF 315 and maintains an overweight rating for the stock. projectionTo hideRelated things>><<
| |||
recommendations | Son's price target lowered to CHF 250 from CHF 260 on Credit Suisse» 14:53 17/05/23 14:53 14:53 Sinc Sonova -6,6616(-10,72%) Credit Suisse analyst... Credit Suisse analyst Christoph Gretler lowered the company's price target for Sonova to CHF 250 from CHF 260 and maintains a neutral rating on the stock. projectionTo hideRelated things>><<
| |||
Downhill | Sonova was demoted to Neutral from Overweight at JPMorgan» 04:34 17/05/23 04:34 04:34 Sinc Sonova -6,6616(-10,72%) JPMorgan analyst David... JPMorgan analyst David Adlington has downgraded Sonova's rating to Neutral from Overweight with a CHF 283 price target, from CHF 290. The analyst sees limited upside potential for earnings and the company's valuation after performance of the company in the second half "was a little lower than expected". projectionTo hideRelated things>><<
|
More than a week ago | ||||
Beginning | Sonova started with Underperform at Bernstein» 04:49 12/05/23 04:49 04:49 Sinc Sonova -0,07(-0,11%) Analyst Bernstein… Bernstein analyst Susannah Ludwig started coverage of Sonova with an underperform rating and a CHF 235 price target. The analyst launched coverage for hearing and dental products, saying limited insurance and easily delayed procedures they are pushing treatments to compete in discretionary markets. Products are more cyclical, but low penetration leaves a theoretical opportunity of $30 billion in hearing and $100 billion in specialty dentistry, the analyst told investors in a research note. Structurally, the company favors dental markets and listen, Bernstein says, it's all about "picking relative winners." projectionTo hideRelated things>><<
|
More than a month ago | ||||
recommendations | Son's price target lowered to CHF 315 from CHF 320 at Barclays» 15:54 03.04.23 15:54 15:54 Sinc Sonova +0,54(+0,93%) Hassan, an analyst at Barclays... Barclays analyst Hassan Al-Wakeel cut the company's price target for Sonova to CHF 315 from CHF 320 and maintains an overweight rating on the stock. projectionTo hideRelated things>><<
| |||
recommendations | Son's price target raised to CHF 290 from CHF 281 at JPMorgan» 15:01 sati 03.04.23 15:01 sati 15:01 sati Sinc Sonova +0,54(+0,93%) JPMorgan has raised... JPMorgan raised the company's target price for Sonova to CHF 290 from CHF 281 and maintains an Overweight rating on the stock. projectionTo hideRelated things>><<
|
more than a quarter ago | ||||
Downhill | Buying into Jefferies reduced Sonova to underperformance» 04:51 25/01/23 04:51 04:51 Sinc Sonova +0,54(+1,08%) Michael, Jefferies analyst... Jefferies analyst Michael Toomey doubled Sonova to Underperform from Buy with a CHF 200 price target, from CHF 340. Consensus expectations do not explain Costco KS contract loss and "moderate" market growth in the second half of fiscal years 2023 and 2024, the analyst told investors in a research note. projectionTo hideRelated things>><<
| |||
recommendations | Son's price target lowered to CHF 250 from CHF 260 at Morgan Stanley» 15:33 01/12/23 15:33 15:33 Sinc Sonova -0,058(-0,12%) Morgan Stanley analyst... Morgan Stanley analyst Robert Davis cut the company's price target for Sonova to CHF 250 from CHF 260 and maintains an equal weight rating on the shares. projectionTo hideRelated things>><<
| |||
Beginning | Sonova began selling to Citi» 06:13 12.12.22 06:13 06:13 Sinc Sonova +0,6405(+1,24%) Veronika, analyst de Citija... Citi analyst Veronika Dubajova initiated coverage of Sonova with a put rating and a CHF 220 price target. Below-average revenue and earnings growth is expected for the European healthcare services and medtech group in 2023, with slightly improved surgical volumes offset by consumer confidence and above-average wage growth, Dubai told investors in a research note. However, the analyst expects the industry to post revenue and earnings growth "well above" Citi strategists' market expectations. Dubajova favors "qualitative growth resistant to macroeconomic headwinds," or where she sees significant sources of growth in the medium term. projectionTo hideRelated things>><<
|